These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22502731)

  • 1. Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C.
    Kim KK; Lange TS; Singh RK; Brard L; Moore RG
    BMC Cancer; 2012 Apr; 12():147. PubMed ID: 22502731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines.
    Ayyagari VN; Hsieh TJ; Diaz-Sylvester PL; Brard L
    BMC Cancer; 2017 Jan; 17(1):49. PubMed ID: 28086831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.
    Kim KK; Kawar NM; Singh RK; Lange TS; Brard L; Moore RG
    Gynecol Oncol; 2011 Jul; 122(1):183-9. PubMed ID: 21529906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of doxorubicin and tetrathiomolybdate on canine hemangiosarcoma cells.
    Sloan CQ; Rodriguez CO
    Am J Vet Res; 2018 Feb; 79(2):219-225. PubMed ID: 29359968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
    Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
    Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
    Ayyagari VN; Diaz-Sylvester PL; Hsieh TJ; Brard L
    PLoS One; 2017; 12(9):e0185111. PubMed ID: 28931042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
    Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
    Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis.
    Wang J; Yuan Z
    Cell Biochem Biophys; 2013 Sep; 67(1):199-206. PubMed ID: 23436279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
    Myatt SS; Redfern CP; Burchill SA
    Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells.
    Osone S; Hosoi H; Kuwahara Y; Matsumoto Y; Iehara T; Sugimoto T
    Int J Cancer; 2004 Nov; 112(2):219-24. PubMed ID: 15352033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS; Burchill SA
    Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.
    Liu J; Li J; Zhang JF; Xin XY
    Int J Mol Sci; 2013 Nov; 14(11):21790-804. PubMed ID: 24192821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
    Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
    Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells.
    Rogalska A; Bukowska B; Marczak A
    Toxicol In Vitro; 2018 Mar; 47():48-62. PubMed ID: 29117515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis.
    Fontana F; Marzagalli M; Raimondi M; Zuco V; Zaffaroni N; Limonta P
    Cell Prolif; 2021 Nov; 54(11):e13111. PubMed ID: 34520051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells.
    Kim KK; Lange TS; Singh RK; Brard L
    BMC Cancer; 2010 Feb; 10():72. PubMed ID: 20184758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
    Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
    Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.